NovaBridge Biosciences (NBP) Prepaid Assets (2018 - 2025)
NovaBridge Biosciences (NBP) reported Prepaid Assets of $6.7 million for Q4 2025, up 102.67% year-over-year from $3.3 million in Q4 2024, and up 22927.59% quarter-over-quarter from $29000.0 in Q3 2025.
NovaBridge Biosciences (NBP) Prepaid Assets (2018 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 8 years of Prepaid Assets data on file, last reported at $6.7 million in Q4 2025.
- Prepaid Assets for Q4 2025 came in at $6.7 million, up 102.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.7 million (up 102.67% YoY), and the FY2025 annual result was $6.7 million, up 102.67% from the prior year.
- Prepaid Assets advanced to $6.7 million in Q4 2025 per NBP's latest filing, from $29000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $29.8 billion in Q4 2021 and troughed at -$4.3 million in Q3 2024.
- A 5-year average of $2.3 billion and a median of $6.7 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2021 and 2022: Prepaid Assets jumped 101093.59% in 2021, then plunged 99.96% in 2022.
- A 5-year view of Prepaid Assets shows it stood at $29.8 billion in 2021, then sank by 99.96% to $11.3 million in 2022, then plunged by 92.73% to $820546.7 in 2023, then soared by 301.56% to $3.3 million in 2024, then surged by 102.67% to $6.7 million in 2025.
- Business Quant data shows NBP's Prepaid Assets at $6.7 million in Q4 2025, $29000.0 in Q3 2025, and $2.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.68 Mn |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | -4.27 Mn |
| Jun 30, 2024 | 22.99 Mn |
| Dec 31, 2023 | 820,546.72 |
| Jun 30, 2023 | 14.11 Mn |
| Dec 31, 2022 | 11.29 Mn |
| Jun 30, 2022 | 15.08 Mn |
| Dec 31, 2021 | 29.85 Bn |
| Jun 30, 2021 | 31.04 Mn |
| Dec 31, 2020 | 29.49 Mn |
| Sep 30, 2020 | 32.38 Mn |
| Jun 30, 2020 | 18.56 Mn |
| Dec 31, 2019 | 19.30 Mn |
| Sep 30, 2019 | 1.76 Mn |
| Dec 31, 2018 | 12.87 Mn |